โ† All KAPS Flashcard Decks

Clinical Procedures and Protocols Flashcards

7 cards from real KAPS practice questions. Tap to flip, then mark Knew It or Still Learning โ€” missed cards come back until you master them.

Read the first 7 Clinical Procedures and Protocols flashcards as text
  1. According to ASHP guidelines, which is the correct method for filtering out particles when drawing up amphotericin B deoxycholate?

    Answer: Use a 5-micron filter

    A 1-micron in-line filter may be used with amphotericin B deoxycholate; a 0.22-micron filter would remove the colloidal drug particles.

  2. A pharmacist is reviewing a patient's medication profile and notes that the patient is taking both St. John's Wort and cyclosporine. What is the expected clinical outcome?

    Answer: Decreased cyclosporine levels and transplant rejection risk

    St. John's Wort is a potent CYP3A4 and P-glycoprotein inducer that significantly reduces cyclosporine blood levels, risking organ rejection.

  3. When performing a final verification check on a compounded sterile preparation, which action is part of the physical inspection step?

    Answer: Checking for particulate matter, color, and clarity

    Physical inspection includes examining the preparation for visible particulates, appropriate color, and clarity against a light and dark background.

  4. A patient with severe hepatic impairment (Child-Pugh Class C) is prescribed a medication primarily eliminated via hepatic metabolism. The anticipated pharmacokinetic change is:

    Answer: Increased half-life and decreased clearance

    Severe hepatic impairment reduces hepatic blood flow and enzyme activity, decreasing clearance and prolonging the drug's half-life.

  5. Which clinical protocol should be followed when administering methotrexate high-dose therapy to prevent nephrotoxicity?

    Answer: Alkalinize the urine with sodium bicarbonate

    Urinary alkalinization with sodium bicarbonate increases methotrexate solubility in urine, preventing precipitation and nephrotoxicity.

  6. During a clinical pharmacist's patient interview, a patient states they take their antihypertensive 'when they feel their blood pressure is high.' This represents which type of adherence barrier?

    Answer: Intentional non-adherence based on health beliefs

    Symptom-driven medication taking reflects intentional non-adherence rooted in the patient's health belief that medication is only needed when symptoms are perceived.

  7. What is the primary purpose of leucovorin rescue following high-dose methotrexate therapy?

    Answer: To bypass dihydrofolate reductase and restore folate function in normal cells

    Leucovorin is a reduced folate that bypasses the DHFR block caused by methotrexate, rescuing normal cells without reversing antitumor effects.